Basir U Tareen

Summary

Affiliation: University of North Dakota
Country: USA

Publications

  1. pmc A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy
    Basir Tareen
    Summa Health System, Department of Urology, Akron, Ohio, USA
    Int J Med Sci 5:62-7. 2008
  2. ncbi request reprint Role of positional instillation of contrast cystography in the algorithm for evaluating children with confirmed pyelonephritis
    Basir U Tareen
    Department of Urology, Northeastern Ohio University College of Medicine, Children s Hospital Medical Center of Akron, Akron, Ohio, USA
    Urology 67:1055-7; discussion 1058-9. 2006
  3. ncbi request reprint Novel method used to test pullout parameters of different nephrostomy catheters
    Basir U Tareen
    Department of Urology, Northeastern Ohio University College of Medicine, Munroe Falls, Ohio 44262, USA
    J Endourol 20:1041-4. 2006
  4. doi request reprint Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort
    Basir Tareen
    Division of Urologic Oncology, Department of Urology, New York University Medical Center, New York, New York 10016, USA
    Urology 73:351-4; discussion 354-5. 2009
  5. doi request reprint Laterality alone should not drive selection of candidates for hemi-ablative focal therapy
    Basir Tareen
    Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York, USA
    J Urol 181:1082-9; discussion 1089-90. 2009
  6. doi request reprint Neurovascular bundle resection: does it improve the margins?
    Herbert Lepor
    Department of Urology, New York University School of Medicine, New York, NY 10016, USA
    Urol Oncol 28:215-8. 2010

Detail Information

Publications6

  1. pmc A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy
    Basir Tareen
    Summa Health System, Department of Urology, Akron, Ohio, USA
    Int J Med Sci 5:62-7. 2008
    ..To evaluate the safety and efficacy of oral Apatone (Vitamin C and Vitamin K3) administration in the treatment of prostate cancer in patients who failed standard therapy...
  2. ncbi request reprint Role of positional instillation of contrast cystography in the algorithm for evaluating children with confirmed pyelonephritis
    Basir U Tareen
    Department of Urology, Northeastern Ohio University College of Medicine, Children s Hospital Medical Center of Akron, Akron, Ohio, USA
    Urology 67:1055-7; discussion 1058-9. 2006
    ....
  3. ncbi request reprint Novel method used to test pullout parameters of different nephrostomy catheters
    Basir U Tareen
    Department of Urology, Northeastern Ohio University College of Medicine, Munroe Falls, Ohio 44262, USA
    J Endourol 20:1041-4. 2006
    ..To present a novel in-vitro pig model for testing the design and function of different internal catheter constructs, along with the resulting exit wound resulting from removal...
  4. doi request reprint Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort
    Basir Tareen
    Division of Urologic Oncology, Department of Urology, New York University Medical Center, New York, New York 10016, USA
    Urology 73:351-4; discussion 354-5. 2009
    ....
  5. doi request reprint Laterality alone should not drive selection of candidates for hemi-ablative focal therapy
    Basir Tareen
    Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York, USA
    J Urol 181:1082-9; discussion 1089-90. 2009
    ..Because many investigators have suggested that ideal candidates for focal therapy are those with unilateral prostate cancer, we evaluated whether these men are at decreased risk for adverse pathological and oncological outcomes...
  6. doi request reprint Neurovascular bundle resection: does it improve the margins?
    Herbert Lepor
    Department of Urology, New York University School of Medicine, New York, NY 10016, USA
    Urol Oncol 28:215-8. 2010
    ..In cases with a 30% risk of side specific extracapsular extension, using the above assumption, the risk of developing a positive surgical margin and biochemical recurrence is only 4.7% and 2%, respectively...